Ascletis Pharma, Inc. (ASCLF)
1.20
0.00 (0.00%)
USD |
OTCM |
Sep 15, 16:00
Ascletis Pharma Price : 1.20 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 1.20 | 1.20 | 1.20 | 1.20 | 0.000 |
| Sep 14, 2026 | 1.21 | 1.21 | 1.20 | 1.20 | 13007.00 |
| Sep 11, 2026 | 1.21 | 1.21 | 1.21 | 1.21 | 4998.00 |
| Sep 10, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 1000.00 |
| Sep 09, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Sep 08, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Sep 04, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 1200.00 |
| Sep 03, 2026 | 1.28 | 1.28 | 1.28 | 1.28 | 0.000 |
| Sep 02, 2026 | 1.28 | 1.28 | 1.28 | 1.28 | 0.000 |
| Sep 01, 2026 | 1.28 | 1.28 | 1.28 | 1.28 | 410.00 |
| Aug 31, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 28, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 1000.00 |
| Aug 27, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 26, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 25, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 24, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 21, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 20, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 19, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 0.000 |
| Aug 18, 2026 | 1.30 | 1.30 | 1.30 | 1.30 | 1650.00 |
| Aug 17, 2026 | 1.34 | 1.34 | 1.34 | 1.34 | 0.000 |
| Aug 14, 2026 | 1.34 | 1.34 | 1.34 | 1.34 | 3000.00 |
| Aug 13, 2026 | 1.205 | 1.205 | 1.205 | 1.205 | 0.000 |
| Aug 12, 2026 | 1.205 | 1.205 | 1.205 | 1.205 | 0.000 |
| Aug 11, 2026 | 1.205 | 1.205 | 1.205 | 1.205 | 0.000 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CStone Pharmaceuticals Co. Ltd. | 0.9109 |
| RemeGen Co., Ltd. | 10.93 |
| InnoCare Pharma Ltd. | 1.55 |
| Adagene, Inc. | 3.16 |
| JW (Cayman) Therapeutics Co. Ltd. | 0.2022 |
Price Related Metrics
| PS Ratio | 9099.69 |
| PEG Ratio | -0.0989 |
| Price to Book Value | 10.80 |
| Earnings Yield | -6.99% |
| Market Cap | 1.187B |
| PEGY Ratio | -0.0989 |